Literature DB >> 9716131

Maintenance of late-phase LTP is accompanied by PKA-dependent increase in AMPA receptor synthesis.

A Nayak1, D J Zastrow, R Lickteig, N R Zahniser, M D Browning.   

Abstract

Long-term potentiation (LTP) is a form of synaptic plasticity that has been extensively studied as a putative mechanism underlying learning and memory. A late phase of LTP occurring 3-5 hours after stimulation and depending on transcription, protein synthesis and cyclic-AMP-dependent protein kinase (protein kinase A, or PKA) has been described, but it is not known whether transcription of presynaptic and/or postsynaptic genes is required to support late-phase LTP. Here we show that late-phase LTP can be obtained in rat hippocampal CA1 mini-slices in which the cell bodies of presynaptic Schaffer collateral/commissural fibres are removed. Thus, transcription of presynaptic genes is not necessary to support maintenance of late-phase LTP. The AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate) receptor is the predominant mediator of the ionotropic response to synaptically released glutamate in the hippocampus and it has been implicated in LTP maintenance. We find that synthesis of AMPA receptor subunits is increased three hours after LTP induction: this effect on the synthesis of the AMPA receptor is blocked by inhibitors of PKA and of transcription. Our results support the idea of a postsynaptic mechanism maintaining late-phase LTP, in which AMPA receptor synthesis is increased as a result of PKA-dependent gene transcription.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9716131     DOI: 10.1038/29305

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  51 in total

1.  Differential distribution of intracellular glutamate receptors in dendrites.

Authors:  M E Rubio; R J Wenthold
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

2.  Slices have more synapses than perfusion-fixed hippocampus from both young and mature rats.

Authors:  S A Kirov; K E Sorra; K M Harris
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

Review 3.  The Venus flytrap of periplasmic binding proteins: an ancient protein module present in multiple drug receptors.

Authors:  C B Felder; R C Graul; A Y Lee; H P Merkle; W Sadee
Journal:  AAPS PharmSci       Date:  1999

4.  Somatic action potentials are sufficient for late-phase LTP-related cell signaling.

Authors:  Serena M Dudek; R Douglas Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

Review 5.  Protein synthesis in the dendrite.

Authors:  Shao Jun Tang; Erin M Schuman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

6.  Co-induction of LTP and LTD and its regulation by protein kinases and phosphatases.

Authors:  Kathryn B Grey; Brian D Burrell
Journal:  J Neurophysiol       Date:  2010-03-24       Impact factor: 2.714

7.  Cerebellar norepinephrine modulates learning of delay classical eyeblink conditioning: evidence for post-synaptic signaling via PKA.

Authors:  M Claire Cartford; Amy Samec; Mathew Fister; Paula C Bickford
Journal:  Learn Mem       Date:  2004-11-10       Impact factor: 2.460

8.  Theta frequency stimulation induces a local form of late phase LTP in the CA1 region of the hippocampus.

Authors:  Yan-You Huang; Eric R Kandel
Journal:  Learn Mem       Date:  2005-11-14       Impact factor: 2.460

9.  The shift of the reversal potential of glutamate-activated chloride current in molluscan neurons caused by 8-Br-cAMP.

Authors:  E I Solntseva; Yu V Bukanova; O V Borisova
Journal:  Dokl Biol Sci       Date:  2004 Nov-Dec

10.  Delayed noradrenergic activation in the dorsal hippocampus promotes the long-term persistence of extinguished fear.

Authors:  Ning Chai; Jian-Feng Liu; Yan-Xue Xue; Chang Yang; Wei Yan; Hui-Min Wang; Yi-Xiao Luo; Hai-Shui Shi; Ji-Shi Wang; Yan-Ping Bao; Shi-Qiu Meng; Zeng-Bo Ding; Xue-Yi Wang; Lin Lu
Journal:  Neuropsychopharmacology       Date:  2014-02-19       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.